IRADIMED CORPORATION to Hold 2019 Third Quarter Financial Results Conference Call on October 30th
October 16, 2019 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Oct. 16, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 third quarter financial results before the market...
IRADIMED CORPORATION Resolves Warning Letter Related to Its Infusion Pump System
October 08, 2019 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Oct. 08, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received a close-out letter from the U.S. Food and Drug Administration resolving...
IRADIMED CORPORATION to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
August 27, 2019 16:15 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Aug. 27, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), today announced that Leslie McDonnell, President and Chief Executive Officer, Roger Susi, Chairman and...
IRADIMED CORPORATION Announces Second Quarter 2019 Financial Results
July 30, 2019 07:00 ET
|
iRadimed Corporation
Reports second quarter 2019 revenue of $9.2 millionReports second quarter 2019 GAAP diluted EPS of $0.17 and non-GAAP diluted EPS of $0.20Updates full year earnings guidance WINTER SPRINGS, Fla.,...
IRADIMED CORPORATION Names Leslie McDonnell as President and Chief Executive Officer
July 29, 2019 16:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., July 29, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that its Board of Directors unanimously appointed Leslie McDonnell, to succeed Roger Susi...
IRADIMED CORPORATION to Hold 2019 Second Quarter Financial Results Conference Call on July 30th
July 16, 2019 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., July 16, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 second quarter financial results before the market...
IRADIMED CORPORATION Announces First Quarter 2019 Financial Results
April 30, 2019 07:00 ET
|
iRadimed Corporation
Reports first quarter 2019 revenue of $8.4 millionReports first quarter 2019 GAAP diluted EPS of $0.15 and non-GAAP diluted EPS of $0.13 WINTER SPRINGS, Fla., April 30, 2019 (GLOBE NEWSWIRE) --...
IRADIMED CORPORATION to Hold 2019 First Quarter Financial Results Conference Call on April 30th
April 16, 2019 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 16, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 first quarter financial results before the market...
IRADIMED CORPORATION Announces FDA 510(k) Clearance for Neonatal Pulse Oximetry and Capnography Monitoring Using its MRI-Compatible Patient Vital Signs Monitor
April 02, 2019 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 02, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received FDA 510(k) clearance for neonatal use of the pulse oximetry (“SpO2”)...
IRADIMED CORPORATION Announces Fourth Quarter 2018 Financial Results
February 06, 2019 07:00 ET
|
iRadimed Corporation
Reports fourth quarter 2018 revenue of $8.3 millionReports fourth quarter 2018 GAAP diluted EPS of $0.14 and non-GAAP diluted EPS of $0.16Announces 2019 full year and first quarter financial...